Ad
related to: clinicaltrials
Search results
Pipeline Moves: Phase III AML trial fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 6 days ago(olaparib) saw a 27-point fall in its LoA, landing at 33% in leiomyosarcoma, after an...
Elon Musk's Neuralink was exempt from sharing trial details — but it's doing it anyway
Quartz· 6 days agoNeuralink registered its Precise robotically implanted brain-computer interface (PRIME) study as a “first-in-human early feasibility study” with the U.S. National Institutes of Health’s (NIH ...
Innovent Delivers Oral Presentation of Clinical Data of A Randomized Controlled Phase 1b Study...
KOIN News 6 Portland· 15 hours agoThe abstract was selected for ASCO Daily News coverage.
Neuralink shares details with NIH - Silicon Valley Business Journal
The Business Journals· 5 days agoDecribed as a "complete quadriplegic," Arbaugh was paralyzed from the shoulders down in a "freak...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 1 day agoFlamingo Therapeutics Presents Poster at ASCO 2024 on Phase II PEMDA-HN Trial for Head and Neck Squamous Cell Carcinoma (HNSCC) PR Newswire LEUVEN, Belgium and STRASBOURG, France and PHILADELPHIA, June 2, 2024 -Trial-in-Progress poster provides
Musk's Neuralink seeks to enroll three patients in brain implant study
Reuters· 6 days agoNeuralink, Elon Musk's brain-chip company, aims to enroll three patients to evaluate its device in a...
U.S. FDA ACKNOWLEDGES ASTELLAS' RESUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR ZOLBETUXIMAB AND...
The Sun Chronicle· 4 days agoIf approved, the investigational therapy would offer a new treatment option for patients with advanced gastric and gastroesophageal junction cancers as the first and only CLDN18.2-targeted therapy ...
Musk’s Neuralink registers brain implant study on US government database
WSAU Wausau· 6 days ago(Reuters) - Elon Musk's brain-chip startup Neuralink has registered details about a study evaluating...
Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer...
Nature· 3 days agoEthical approval to generate patient-derived models was obtained through the Tracking Cancer Evolution through Therapy (TRACERx) clinical study (REC reference: 13/LO/1546; https://clinicaltrials ...
Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion...
Char-Koosta News· 2 days agoMore updated data from the Phase 1 study including in non-small cell lung cancer will be presented...
